Join the club for FREE to access the whole archive and other member benefits.

Medicines Discovery Catapult

Government funded, not-for-profit organisation

Medicines Discovery Catapult is a national Life Sciences service that reshapes drug discovery to deliver better treatments for patients

We partner with innovators across the sector, helping them turn bold scientific ideas into real-world impact.

Our model supports drug discovery companies at every step, from early research through to commercialisation, by providing access to world-class science, laboratories, technologies, and expertise.

We de-risk drug discovery, run collaborative R&D partnerships, and reinvest in our sector to drive growth.

Visit website: https://md.catapult.org.uk/

 md.catapult

 meddisccat

 MedDiscCat

 UC0YUefHzYkhmOhfCAjm-aaA

Details last updated 19-Dec-2020

Medicines Discovery Catapult News

Alchemab awarded 1.7 million grant to develop Huntington’s disease therapy

Alchemab awarded 1.7 million grant to develop Huntington’s disease therapy

Alchemab Therapeutics - 16-Dec-2022

New antibody approach aims to slow or halt Huntington’s disease progression

Nanotech nurtures unique treatment for inoperable cancers

Nanotech nurtures unique treatment for inoperable cancers

pharmaphorum - 18-Dec-2020

Innovate UK is funding specialists of nanotechnology & bioimaging to cure cancer

People at Medicines Discovery Catapult

John P. Overington

Chief informatics Officer at the Medicines Discovery Catapult.

Graeme Wilkinson

Head of Virtual Drug Discovery at Medicines Discovery Catapult.